VYVANSE lisdexamfetamine dimesilate 20 mg capsules bottle - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
Product details |
Supply Impact Dates |
Further Details |
VYVANSE lisdexamfetamine dimesilate 20 mg capsules bottle AUST R: 284019Active ingredients:
lisdexamfetamine dimesilate
Dosage form: Capsule, hard
Sponsor: Takeda Pharmaceuticals Australia Pty Ltd
Phone: 1800012612
|
From 14 Jun 2024 to 21 Aug 2024
|
Shortage status: Resolved
Availability: Available
Reason: Unexpected increase in consumer demand
|